KR102061482B1 - 섬유근육통 및 만성 피로 증후군을 치료하기 위한 (1r,4r)-6'-플루오로-(N-메틸- 또는 N,N-디메틸-)-4-페닐-4',9'-디하이드로-3'H-스피로-[사이클로헥산-1,1'-피라노[3,4,b]인돌]-4-아민 - Google Patents

섬유근육통 및 만성 피로 증후군을 치료하기 위한 (1r,4r)-6'-플루오로-(N-메틸- 또는 N,N-디메틸-)-4-페닐-4',9'-디하이드로-3'H-스피로-[사이클로헥산-1,1'-피라노[3,4,b]인돌]-4-아민 Download PDF

Info

Publication number
KR102061482B1
KR102061482B1 KR1020147024696A KR20147024696A KR102061482B1 KR 102061482 B1 KR102061482 B1 KR 102061482B1 KR 1020147024696 A KR1020147024696 A KR 1020147024696A KR 20147024696 A KR20147024696 A KR 20147024696A KR 102061482 B1 KR102061482 B1 KR 102061482B1
Authority
KR
South Korea
Prior art keywords
fibromyalgia
fluoro
spiro
dihydro
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020147024696A
Other languages
English (en)
Korean (ko)
Other versions
KR20140130695A (ko
Inventor
슈테파니 프로쉬
클라우스 린츠
페트라 블롬스-푼케
Original Assignee
그뤼넨탈 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 그뤼넨탈 게엠베하 filed Critical 그뤼넨탈 게엠베하
Publication of KR20140130695A publication Critical patent/KR20140130695A/ko
Application granted granted Critical
Publication of KR102061482B1 publication Critical patent/KR102061482B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
KR1020147024696A 2012-02-03 2013-02-01 섬유근육통 및 만성 피로 증후군을 치료하기 위한 (1r,4r)-6'-플루오로-(N-메틸- 또는 N,N-디메틸-)-4-페닐-4',9'-디하이드로-3'H-스피로-[사이클로헥산-1,1'-피라노[3,4,b]인돌]-4-아민 Expired - Fee Related KR102061482B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12000743 2012-02-03
EP12000743.0 2012-02-03
PCT/EP2013/051979 WO2013113857A1 (en) 2012-02-03 2013-02-01 (1r,4r)-6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome

Publications (2)

Publication Number Publication Date
KR20140130695A KR20140130695A (ko) 2014-11-11
KR102061482B1 true KR102061482B1 (ko) 2020-01-03

Family

ID=47628188

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147024696A Expired - Fee Related KR102061482B1 (ko) 2012-02-03 2013-02-01 섬유근육통 및 만성 피로 증후군을 치료하기 위한 (1r,4r)-6'-플루오로-(N-메틸- 또는 N,N-디메틸-)-4-페닐-4',9'-디하이드로-3'H-스피로-[사이클로헥산-1,1'-피라노[3,4,b]인돌]-4-아민

Country Status (23)

Country Link
US (1) US20130202701A1 (https=)
EP (1) EP2809320B1 (https=)
JP (1) JP6126134B2 (https=)
KR (1) KR102061482B1 (https=)
CN (1) CN104168897B (https=)
AU (1) AU2013214223B2 (https=)
BR (1) BR112014019136A8 (https=)
CA (1) CA2863572C (https=)
CY (1) CY1118799T1 (https=)
DK (1) DK2809320T3 (https=)
EA (1) EA025500B1 (https=)
ES (1) ES2629211T3 (https=)
HR (1) HRP20170581T1 (https=)
IL (1) IL233871B (https=)
LT (1) LT2809320T (https=)
MX (1) MX353740B (https=)
NZ (1) NZ629800A (https=)
PL (1) PL2809320T3 (https=)
PT (1) PT2809320T (https=)
RS (1) RS56097B1 (https=)
SI (1) SI2809320T1 (https=)
WO (1) WO2013113857A1 (https=)
ZA (1) ZA201406447B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6673924B2 (ja) 2015-01-23 2020-03-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 肝機能障害および／または腎機能障害を有する対象における疼痛を治療するためのセブラノパドール

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005066183A1 (de) 2003-12-23 2005-07-21 Grünenthal GmbH Spirocyclische cyclohexan-derivate mit affinität zum orl1-rezeptor
US20080125475A1 (en) 2006-09-29 2008-05-29 Grunenthal Gmbh Mixed ORL1/mu-agonists for the treatment of pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US7354925B2 (en) * 2004-03-29 2008-04-08 Pfizer Inc. Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists
AU2007254751A1 (en) * 2006-05-31 2007-12-13 Sepracor Inc. Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005066183A1 (de) 2003-12-23 2005-07-21 Grünenthal GmbH Spirocyclische cyclohexan-derivate mit affinität zum orl1-rezeptor
US20080125475A1 (en) 2006-09-29 2008-05-29 Grunenthal Gmbh Mixed ORL1/mu-agonists for the treatment of pain

Also Published As

Publication number Publication date
AU2013214223B2 (en) 2017-03-23
SI2809320T1 (sl) 2017-07-31
IL233871B (en) 2018-06-28
CN104168897B (zh) 2016-09-28
EP2809320A1 (en) 2014-12-10
KR20140130695A (ko) 2014-11-11
JP2015505553A (ja) 2015-02-23
US20130202701A1 (en) 2013-08-08
MX2014008865A (es) 2014-08-27
JP6126134B2 (ja) 2017-05-10
BR112014019136A8 (pt) 2017-07-11
EA025500B1 (ru) 2016-12-30
LT2809320T (lt) 2017-05-25
WO2013113857A1 (en) 2013-08-08
EA201400857A1 (ru) 2015-01-30
CN104168897A (zh) 2014-11-26
PL2809320T3 (pl) 2017-09-29
RS56097B1 (sr) 2017-10-31
IL233871A0 (en) 2014-09-30
CA2863572C (en) 2019-08-27
HK1199218A1 (en) 2015-06-26
BR112014019136A2 (https=) 2017-06-20
CA2863572A1 (en) 2013-08-08
ZA201406447B (en) 2016-02-24
DK2809320T3 (en) 2017-05-15
MX353740B (es) 2018-01-26
CY1118799T1 (el) 2018-01-10
PT2809320T (pt) 2017-06-30
AU2013214223A1 (en) 2014-09-18
HRP20170581T1 (hr) 2017-06-16
ES2629211T3 (es) 2017-08-07
NZ629800A (en) 2016-06-24
EP2809320B1 (en) 2017-03-22

Similar Documents

Publication Publication Date Title
JP2002532393A (ja) エキソ−ｒ−メカミラミン製剤および治療におけるその使用
JP3688735B2 (ja) （Ｓ）−（−）−α−エチル−２−オキソ−１−ピロリジ ンアセトアミドを用いる不安の治療法
KR20150095681A (ko) 보르티옥세틴 및 도네페질을 포함하는 조성물
Schwarz et al. Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization
BG107185A (bg) Метод за получаване на лекарствено средство за лечение на сексуална дисфункция с апоморфин при определени нива на плазмена концентрация
JP2006176503A (ja) 脳血管障害を伴うアルツハイマー病治療薬
KR20150020160A (ko) 과민성 방광의 치료를 위한 무스카린 수용체 길항제 및 베타―3 아드레날린 수용체 작용제의 조합물
KR102061482B1 (ko) 섬유근육통 및 만성 피로 증후군을 치료하기 위한 (1r,4r)-6'-플루오로-(N-메틸- 또는 N,N-디메틸-)-4-페닐-4',9'-디하이드로-3'H-스피로-[사이클로헥산-1,1'-피라노[3,4,b]인돌]-4-아민
KR20230015433A (ko) 운동실조를 치료하기 위한 아세틸 류신과 4-아미노피리딘 또는 아세타졸아미드의 조합물
EP2131838B1 (en) A medicament for treating schizophrenia comprising cilostazol
HK1199218B (en) (1r,4r)-6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro-[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for treating fibromyalgia and chronic fatigue syndrome
Heithoff et al. 1121 Desloratadine improves quality of life in patients with seasonal allergic rhinitis
CN112043700A (zh) 盐酸去亚甲基四氢小檗碱在制备预防或治疗神经退行性疾病药物中的应用
TWI313607B (https=)
JP3187413B2 (ja) 記憶学習力低下改善剤
JP4615849B2 (ja) プロパフェノン含有神経因性疼痛の鎮痛剤
EP1997486B1 (en) Therapeutic agent for functional brain disease
US20220362202A1 (en) Drug For Treating And Preventing Dementia
WO2000066105A9 (en) Treatment of epilepsy with imino sugars
HK1163526B (en) A medicament for treating schizophrenia comprising cilostazol
JP2005154368A (ja) ジソピラミド含有神経因性疼痛の鎮痛剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20221227

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20221227